Mirum Pharma showcases LIVMARLI and Volixibat data at AASLD
November 7, 2025
Mirum Pharmaceuticals, Inc. , a biopharmaceutical company focused on rare liver disorders, announced that it will showcase multiple presentations featuring data from its LIVMARLI (maralixibat) and Volixibat clinical